Status:
UNKNOWN
Pharmacokinetic Study in Patients Receiving Posaconazole Therapy in Taiwan
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Pharmacokinetics
Posaconazole
Eligibility:
All Genders
13+ years
Brief Summary
The purpose of this study is to investigate the factors influencing pharmacokinetic and pharmacodynamic properties of new antifungal agent, posaconazole in Taiwanese patients.
Detailed Description
Invasive fungal infection (IFI) may cause high mortality and morbidity in immune- compromised patients. Posaconazole, a new triazole antifungal agent with broad spectrum coverage, was approved for bot...
Eligibility Criteria
Inclusion
- Patients receiving posaconazole therapy
- Patients aged 13 years old or more
Exclusion
- No posaconazole plasma concentration available
Key Trial Info
Start Date :
March 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2017
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT02217761
Start Date
March 1 2012
End Date
July 1 2017
Last Update
August 15 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.